These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

80 related items for PubMed ID: 10732866

  • 1. Flow cytometry of p53 protein expression in some hematological malignancies.
    Koníková E, Kusenda J, Babusíková O.
    Neoplasma; 1999; 46(6):368-76. PubMed ID: 10732866
    [Abstract] [Full Text] [Related]

  • 2. P53 protein expression in human leukemia and lymphoma cells.
    Koníková E, Kusenda J.
    Neoplasma; 2001; 48(4):290-8. PubMed ID: 11712681
    [Abstract] [Full Text] [Related]

  • 3. Argyrophilic nucleolar organizer regions (AgNORs) in relation to p53 and bcl-2 protein expression in leukemia patients.
    Klobusická M, Kusenda J, Babusíková O.
    Neoplasma; 2003; 50(6):408-15. PubMed ID: 14689061
    [Abstract] [Full Text] [Related]

  • 4. Differential expression of BCL-2 oncoprotein and Fas antigen on normal peripheral blood and leukemic bone marrow cells. A flow cytometric analysis.
    Molica S, Mannella A, Dattilo A, Levato D, Iuliano F, Peta A, Consarino C, Magro S.
    Haematologica; 1996; 81(4):302-9. PubMed ID: 8870373
    [Abstract] [Full Text] [Related]

  • 5. Antigen modulation followed by quantitative flow cytometry of B-chronic lymphocytic leukemia cells after treatment.
    Kusenda J, Babusíková O.
    Neoplasma; 2004; 51(2):97-102. PubMed ID: 15190418
    [Abstract] [Full Text] [Related]

  • 6. Leukemia markers expression of peripheral blood vs bone marrow blasts using flow cytometry.
    Rezaei A, Adib M, Mokarian F, Tebianian M, Nassiri R.
    Med Sci Monit; 2003 Aug; 9(8):CR359-62. PubMed ID: 12942032
    [Abstract] [Full Text] [Related]

  • 7. Immunocytochemical detection of bcl-2 and p53 proteins in B-chronic lymphocytic leukemia patients.
    Klobusická M, Kusenda J, Babusíková O.
    Neoplasma; 2002 Aug; 49(6):387-93. PubMed ID: 12584586
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Expression of p53 and bcl-2 proteins in acute leukemias: an immunocytochemical study.
    Klobusická M, Kusenda J, Babusíkova O.
    Neoplasma; 2001 Aug; 48(6):489-95. PubMed ID: 11949843
    [Abstract] [Full Text] [Related]

  • 11. High expression of urokinase plasminogen activator receptor (UPA-R) in acute myeloid leukemia (AML) is associated with worse prognosis.
    Graf M, Reif S, Hecht K, Pelka-Fleischer R, Pfister K, Schmetzer H.
    Am J Hematol; 2005 May; 79(1):26-35. PubMed ID: 15849776
    [Abstract] [Full Text] [Related]

  • 12. p53 flow cytometry evaluation in leukemias: correlation to factors affecting clinical outcome.
    Cavalcanti GB, Scheiner MA, Simões Magluta EP, Vasconcelos FC, Klumb CE, Maia RC.
    Cytometry B Clin Cytom; 2010 Jul; 78(4):253-9. PubMed ID: 20198607
    [Abstract] [Full Text] [Related]

  • 13. Increased myeloid precursors in regenerating bone marrow; implications for detection of minimal residual disease in acute myeloid leukemia.
    Zeleznikova T, Stevulova L, Kovarikova A, Babusikova O.
    Neoplasma; 2007 Jul; 54(6):471-7. PubMed ID: 17949229
    [Abstract] [Full Text] [Related]

  • 14. Altered expression of p53 and MDM2 proteins in hematological malignancies.
    Koníková E, Kusenda J.
    Neoplasma; 2003 Jul; 50(1):31-40. PubMed ID: 12687276
    [Abstract] [Full Text] [Related]

  • 15. Quantitative immunocytofluorometry--new parameters for the definition of leukemia cells.
    Babusíková O, Glasová M, Stasáková J, Kusenda J, Koníková E.
    Neoplasma; 1997 Jul; 44(6):348-55. PubMed ID: 9605006
    [Abstract] [Full Text] [Related]

  • 16. High expression of costimulatory molecules correlates with low relapse-free survival probability in acute myeloid leukemia (AML).
    Graf M, Reif S, Hecht K, Pelka-Fleischer R, Kroell T, Pfister K, Schmetzer H.
    Ann Hematol; 2005 May; 84(5):287-97. PubMed ID: 15592672
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Different levels of CD52 antigen expression evaluated by quantitative fluorescence cytometry are detected on B-lymphocytes, CD 34+ cells and tumor cells of patients with chronic B-cell lymphoproliferative diseases.
    Klabusay M, Sukova V, Coupek P, Brychtova Y, Mayer J.
    Cytometry B Clin Cytom; 2007 Sep; 72(5):363-70. PubMed ID: 17428002
    [Abstract] [Full Text] [Related]

  • 20. Flow cytometric assessment of autologous gammadelta T cells in patients with acute myeloid leukemia: potential effector cells for immunotherapy?
    Aswald JM, Wang XH, Aswald S, Lutynski A, Minden MD, Messner HA, Keating A.
    Cytometry B Clin Cytom; 2006 Nov 15; 70(6):379-90. PubMed ID: 16977635
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 4.